Categories

GMP testing

GMP testing

GMP testing comprises those stages of drug development when an investigational drug becomes a pharmaceutical drug. ‘A drug prototype’ should be administered to human individuals in clinical trial phases II and III.

If a candidate drug was successfully confirmed in clinical trials and its manufacturing is approved, QM/batch release protocols may include DNA/RNA-based methods and/or cell techniques.

The GMP methods we offer are specialized in DNA/RNA technology and/or cell techniques. They are required for QM/batch release in the field of gene therapy, biomolecules drugs such as vaccines and proteins.

Residual DNA tests Residual DNA tests Residual DNA tests
Show product
Adenovirus detection Adenovirus detection Adenovirus detection
Show product
Endotoxin detection Endotoxin detection Endotoxin detection
Show product
Mycoplasma detection Mycoplasma detection Mycoplasma detection
Show product
DNA/RNA integrity DNA/RNA integrity DNA/RNA integrity
Show product
Mycobacterium tuberculosis Mycobacterium tuberculosis Mycobacterium tuberculosis
Show product